122 related articles for article (PubMed ID: 16786126)
1. Activation of the PKB/Akt pathway in histological benign prostatic tissue adjacent to the primary malignant lesions.
Merseburger AS; Hennenlotter J; Simon P; Müller CC; Kühs U; Knüchel-Clarke R; Moul JW; Stenzl A; Kuczyk MA
Oncol Rep; 2006 Jul; 16(1):79-83. PubMed ID: 16786126
[TBL] [Abstract][Full Text] [Related]
2. Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancer.
Merseburger AS; Kramer MW; Hennenlotter J; Simon P; Knapp J; Hartmann JT; Stenzl A; Serth J; Kuczyk MA
Prostate; 2008 Jan; 68(1):72-7. PubMed ID: 18008332
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of Akt signaling pathway parameters in prostate needle biopsies derived from benign, adjacent and cancerous tissue.
Waalkes S; Simon P; Hennenlotter J; Knapp J; Tezval H; Serth J; Stenzl A; Kuczyk MA; Merseburger AS
Oncol Rep; 2010 May; 23(5):1257-60. PubMed ID: 20372838
[TBL] [Abstract][Full Text] [Related]
4. Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men.
Shimizu Y; Segawa T; Inoue T; Shiraishi T; Yoshida T; Toda Y; Yamada T; Kinukawa N; Terada N; Kobayashi T; Kinoshita H; Kamoto T; Nakamura E; Ogawa O
BJU Int; 2007 Sep; 100(3):685-90. PubMed ID: 17542985
[TBL] [Abstract][Full Text] [Related]
5. p27Kip1 is inactivated in human colorectal cancer by cytoplasmic localization associated with activation of Akt/PKB.
Bottini C; Platini F; Rinaldi M; Leutner M; Alabiso O; Garavoglia M; Tessitore L
Int J Oncol; 2009 Jan; 34(1):69-77. PubMed ID: 19082479
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
Rehman I; Azzouzi AR; Cross SS; Deloulme JC; Catto JW; Wylde N; Larre S; Champigneuille J; Hamdy FC
Hum Pathol; 2004 Nov; 35(11):1385-91. PubMed ID: 15668896
[TBL] [Abstract][Full Text] [Related]
7. The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells.
Levitt RJ; Zhao Y; Blouin MJ; Pollak M
Cancer Lett; 2007 Oct; 255(2):300-6. PubMed ID: 17602833
[TBL] [Abstract][Full Text] [Related]
8. Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies.
Hansel DE; DeMarzo AM; Platz EA; Jadallah S; Hicks J; Epstein JI; Partin AW; Netto GJ
J Urol; 2007 May; 177(5):1736-40. PubMed ID: 17437801
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive analysis of transcript signatures of the phosphatidylinositol-3 kinase/protein kinase B signal-transduction pathway in prostate cancer.
Hellwinkel OJ; Rogmann JP; Asong LE; Luebke AM; Eichelberg C; Ahyai S; Isbarn H; Graefen M; Huland H; Schlomm T
BJU Int; 2008 Jun; 101(11):1454-60. PubMed ID: 18336616
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
Shankar S; Srivastava RK
Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
12. Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs.
Lincová E; Hampl A; Pernicová Z; Starsíchová A; Krcmár P; Machala M; Kozubík A; Soucek K
Biochem Pharmacol; 2009 Sep; 78(6):561-72. PubMed ID: 19433066
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of neuropilin-1 in malignant and benign prostatic stromal tissue.
Vanveldhuizen PJ; Zulfiqar M; Banerjee S; Cherian R; Saxena NK; Rabe A; Thrasher JB; Banerjee SK
Oncol Rep; 2003; 10(5):1067-71. PubMed ID: 12883660
[TBL] [Abstract][Full Text] [Related]
14. Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression.
Osman I; Dai J; Mikhail M; Navarro D; Taneja SS; Lee P; Christos P; Shen R; Nanus DM
Cancer; 2006 Dec; 107(11):2628-36. PubMed ID: 17083125
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
16. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.
Soulitzis N; Karyotis I; Delakas D; Spandidos DA
Int J Oncol; 2006 Aug; 29(2):305-14. PubMed ID: 16820871
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling in R-flurbiprofen-treated prostate cancer: R-Flurbiprofen regulates prostate stem cell antigen through activation of AKT kinase.
Zemskova M; Wechter W; Bashkirova S; Chen CS; Reiter R; Lilly MB
Biochem Pharmacol; 2006 Nov; 72(10):1257-67. PubMed ID: 16949054
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of p27(Kip 1) cyclin-dependent kinase inhibitor in prostate cancer: distinct expression in various prostate cells associating with tumor stage and grades.
Nikoleishvili D; Pertia A; Tsintsadze O; Gogokhia N; Chkhotua A
Georgian Med News; 2007 Feb; (143):34-8. PubMed ID: 17404436
[TBL] [Abstract][Full Text] [Related]
19. PTEN and p27Kip1 are not downregulated in the majority of renal cell carcinomas--implications for Akt activation.
Hennenlotter J; Ohneseit PA; Simon P; Merseburger AS; Serth J; Kuehs U; Kramer M; Hartmann JT; Stenzl A; Kuczyk MA
Oncol Rep; 2008 May; 19(5):1141-7. PubMed ID: 18425369
[TBL] [Abstract][Full Text] [Related]
20. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M
J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
